Hubert Schrezenmeier to Cohort Studies
This is a "connection" page, showing publications Hubert Schrezenmeier has written about Cohort Studies.
Connection Strength
0.059
-
Independent Side-by-Side Validation and Comparison of 4 Serological Platforms for SARS-CoV-2 Antibody Testing. J Infect Dis. 2021 03 03; 223(5):796-801.
Score: 0.041
-
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. J Clin Invest. 2021 07 15; 131(14).
Score: 0.011
-
Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study. PLoS One. 2017; 12(1):e0169512.
Score: 0.008